AMINOSTAB
As listed in the register: AMINOSTAB, solution injectable pour perfusion en flacon
340 mg + 1600 mg + 1270 mg + qsp 56 mg + 680 mg + 560 mg + 790 mg + 790 mg + 450 mg + 560 mg + 190 mg + 730 mg + 790 mg + 560 mg + 1130 mg + 560 mg + 680 mg + 23 mg + qsp 56 mg · solution pour perfusion
- Prescription status not stated
- Made by
- FRESENIUS KABI FRANCE
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | FRESENIUS KABI FRANCE |
|---|---|
| Active substance | Aspartique (Acide) + Alanine + Lysine (Acétate De) + Cystéine + Histidine + Isoleucine + Leucine + Phénylalanine + Sérine + Thréonine + Tryptophane L + Valine + Glycine + Glutamique (Acide) + Arginine + Méthionine + Proline + Tyrosine + L-Cystine |
| Strength | 340 mg + 1600 mg + 1270 mg + qsp 56 mg + 680 mg + 560 mg + 790 mg + 790 mg + 450 mg + 560 mg + 190 mg + 730 mg + 790 mg + 560 mg + 1130 mg + 560 mg + 680 mg + 23 mg + qsp 56 mg |
| Form | solution pour perfusion |
| Route | intraveineuse |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure nationale |
| Name in the register | AMINOSTAB, solution injectable pour perfusion en flacon |
| Packs | 1 flacon(s) en verre de 500 ml |
| CIS | 64743130 |
| CIP13 | 3400955695264 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).